wtx-330
·Code: WTX-330
wtx-330: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | Phase 1/Phase 2 |
Clinical Trials (1)
A Phase 1b/2 Multisite Dose- and Regimen-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma (NHL)
Frequently asked questions
Who is developing wtx-330?
wtx-330 is being developed by Werewolf Therapeutics, Inc..
How many clinical trials involve wtx-330?
BioSniper tracks 1 clinical trial involving wtx-330.
Get deeper analysis on wtx-330
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis